Prolonged Bisphosphonate Release after Treatment in Children
Authors:
- Socrates E. PapapoulosSPSocrates E. Papapoulos
- Serge C.L.M. CremersSCSerge C.L.M. Cremers
- 8 March 2007
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (10) , 1075-1076
Abstract
Bisphosphonates are widely used in the management of osteoporosis. They are cleared rapidly from the circulation, with about half the administered dose taken up by the skeleton and the rest excreted unmetabolized by the kidneys.1 At the bone surface, bisphosphonates suppress bone resorption and are embedded in bone. The embedded bisphosphonate is released slowly from bone, presumably after the resumption of bone remodeling at previously exposed sites.Keywords
This publication has 4 references indexed in Scilit:
- Pharmacokinetics/Pharmacodynamics of BisphosphonatesClinical Pharmacokinetics, 2005
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenNew England Journal of Medicine, 2004
- Long-Term Effects of Bisphosphonates on the Growing Skeleton: Studies of Young Patients with Severe OsteoporosisMedicine, 1997
- Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronateThe Journal of Clinical Endocrinology & Metabolism, 1995